PRN: Central Nervous System Disorders Pipeline Database 2017: MS, Depression, Alzheimer's, Parkinson's, ADHD, Schizophrenia, Epilepsy, Migraine and Huntington's - Research and Markets

19/gen/2017 17:10:12 PR Newswire Turismo Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

Central Nervous System Disorders Pipeline Database 2017: MS, Depression, Alzheimer's, Parkinson's, ADHD, Schizophrenia, Epilepsy, Migraine and Huntington's - Research and Markets

 
[19-January-2017]
 

DUBLIN, Jan 19, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Central Nervous System Disorders Pipeline Database - 2017" drug pipelines to their offering.

Central Nervous System Disorders Pipeline Highlights Database - 2017, provides most up-to-date information on key pipeline products in the global Central Nervous System (CNS) disorders Drug market.

It covers emerging therapies for CNS indications in active clinical development stages including early and late stage clinical trials. Key indications covered in this database include Multiple Sclerosis, Depression, Alzheimer's disease, Parkinson's disease, ADHD, Schizophrenia, Epilepsy, Migraine, and Huntington's disease.

The pipeline data presented in this database helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

By Indication:
The database presents pipeline by CNS indications. Key indications covered in this database include Multiple Sclerosis, Depression, Alzheimer's disease, Parkinson's disease, ADHD, Schizophrenia, Epilepsy, Migraine, and Huntington's disease.

By Clinical Trial Stages:
The database provides CNS disorders pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

By Drug Mechanism Classes:
The database provides CNS disorders pipeline products by their dominant drug mechanism class. This helps executives categorize products based on their d! rug class and also assess the strengths and weaknesses of compounds.

By Company:
The database provides CNS disorders pipeline products by the company.

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/n6p8ms/central_nervous

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl